IceCure Medical Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

January 19, 2024

https://www.globenewswire.com/news-release/2024/01/12/2808802/0/en/IceCure-Medical-Regains-Compliance-with-Nasdaq-Minimum-Closing-Bid-Price-Rule.html

CAESAREA, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) — IceCure Medical Ltd. (Nasdaq:ICCM) (“IceCure” or the “Company”), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it has received a written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities, including the Company’s ordinary shares, to maintain a minimum bid price of $1.00 per share.

Read more at globenewswire.com

Related news for (ICCM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.